<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>My radiant padlet by </title>
      <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2022-12-04 15:31:12 UTC</pubDate>
      <lastBuildDate>2026-02-03 02:56:10 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title></title>
         <author>lillipavicic</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408101907</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1906350482/06fabdb1b9fc713f687abea85a14593c/Screen_Shot_2022_12_04_at_11_00_38_AM.png" />
         <pubDate>2022-12-04 16:08:27 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408101907</guid>
      </item>
      <item>
         <title>Experimental Flow</title>
         <author>qintianwang</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408114905</link>
         <description><![CDATA[<div>Grouping:<br><br></div><ul><li>Experimental Autoimmune Encephalomyelitis (EAE) induction in 0 M<ul><li>Two control groups: age-matched controls (AMC) either received subdermal inoculation with complete Freund's adjuvant (CFA, n = 10) or did not receive any injections (n = 10) during the experiment.</li></ul></li><li>Mice that had been exposed to EAE were split into two groups and performed intraocular injections in the 10 M.&nbsp;<ul><li>In one group, 1 μl of scAAV-NDI1 triple capsid mutant was intravitreally injected</li><li>The other group received 1 μl of scAAVmCherry&nbsp;</li><li>As extra injection controls, 1 μl of scAAV-mCherry was injected into CFA mice.</li></ul></li></ul><div><br></div><div>Timeline:<br><br>&nbsp; &nbsp; • First treatment of control groups took place in 0 M to see if other factors may have potentially had an effect on the decrease in PERG and confirm the effect of the treatment in the experimental group.<br><br>&nbsp; &nbsp; • PERG/SD-OCT was performed between 1 M and 9 M to measure if there were changes in normal visual function<br><br>&nbsp; &nbsp; • Second treatment of control groups took place in 10 M to see if the injection of NDI1 can improve visual function in EAE mice and the PERG and SD-OCT were used to test the effect in 12 M<br><br>&nbsp; &nbsp; • Mice were euthanized 2 months post-AAV injections to perform other relevant tests and analysis.<br>&nbsp; &nbsp; &nbsp;</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1778115986/f0015aa96524a4b5f48bad67b8a09f2f/45C3388E_E684_44E3_BA66_74BD46E8C725.jpeg" />
         <pubDate>2022-12-04 16:31:42 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408114905</guid>
      </item>
      <item>
         <title>What is Multiple Sclerosis (MS)?</title>
         <author>lillipavicic</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408115910</link>
         <description><![CDATA[<div>https://www.news-medical.net/health/Types-of-Multiple-Sclerosis-%28MS%29.aspx</div>]]></description>
         <enclosure url="https://www.contactlenses.co.uk/data/education/edupagecontents/58cee378d428e.jpg" />
         <pubDate>2022-12-04 16:33:22 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408115910</guid>
      </item>
      <item>
         <title>Methods</title>
         <author>eesharehman</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408116937</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-12-04 16:35:00 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408116937</guid>
      </item>
      <item>
         <title>Results</title>
         <author>eesharehman</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408117004</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-12-04 16:35:06 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408117004</guid>
      </item>
      <item>
         <title>Discussion</title>
         <author>eesharehman</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408117059</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-12-04 16:35:11 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408117059</guid>
      </item>
      <item>
         <title>INTRODUCTION</title>
         <author>lillipavicic</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408118965</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2022-12-04 16:38:32 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408118965</guid>
      </item>
      <item>
         <title>Pattern Electroretinography (PERG)</title>
         <author>qintianwang</author>
         <link>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408151777</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1778115986/e4ed96627ab8d6e76953abfc2bf798e4/7EC7F398_05A5_4847_9A1E_AE4EB6DC4CAC.jpeg" />
         <pubDate>2022-12-04 17:34:57 UTC</pubDate>
         <guid>https://padlet.com/lillipavicic/avsvsct3t1vxkwp3/wish/2408151777</guid>
      </item>
   </channel>
</rss>
